Pfizer Venture Investments — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
A biopharmaceutical company developing targeted oncology medicines, with a focus on treatments for patients of all ages including children with cancers such as pediatric low-grade glioma (pLGG).
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
MICHAEL J. KAUFMAN(Executive Officer)DONALD BERGSTROM(Executive Officer)ANNA PROTOPAPAS(Executive Officer, Director)DAVID MOTT(Director)TIMOTHY LOWINGER(Executive Officer)EVA JACK(Executive Officer)
Co-investorsBain Capital Life SciencesF-Prime Capital PartnersLightstone VenturesNew Enterprise Associates (NEA)Nextech InvestRho Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.